2022
DOI: 10.1007/s12011-022-03387-0
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Selenium-Mediated Notch/Hes1 Signaling Pathway in Kashin–Beck Disease Patients and Cartilage Injury Models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…The ability of chronic stress to elevate the expression of CTSK is thus likely to have been involved in Notch signaling has been shown to control cell fates and signal integration in development [39]. Laboratory evidence indicates that among the Notch receptors, Notch1/ Hes1 signaling modulates not only cell proliferation but also apoptosis in the initiation and progression of tumors and cardiovascular diseases [26,40]. One of our earlier investigations demonstrated that CTSK deficiency decreased the levels of the ischemic muscle c-Notch1 protein [26].…”
Section: Discussionmentioning
confidence: 99%
“…The ability of chronic stress to elevate the expression of CTSK is thus likely to have been involved in Notch signaling has been shown to control cell fates and signal integration in development [39]. Laboratory evidence indicates that among the Notch receptors, Notch1/ Hes1 signaling modulates not only cell proliferation but also apoptosis in the initiation and progression of tumors and cardiovascular diseases [26,40]. One of our earlier investigations demonstrated that CTSK deficiency decreased the levels of the ischemic muscle c-Notch1 protein [26].…”
Section: Discussionmentioning
confidence: 99%
“…In this case, epiphyseal plate lesions in KBD patients can be observed, and the expression of COLII and GPX1 in chondrocytes is reduced, indicating a potential association between the observed epiphyseal plate lesions in KBD patients and decreased chondrocyte anabolism, metabolism, and antioxidant capacity ( 72 ). Additionally, Zhang et al reported a potential correlation between the reduced plasma Se levels observed in KBD patients and inadequate dietary Se intake ( 73 ). Se deficiency may be involved in the pathological process of KBD by activating the Notch/Hes1 signalling pathway, leading to excessive chondrocyte apoptosis.…”
Section: Selenium and Kashin-beck Diseasementioning
confidence: 99%
“…Se deficiency may be involved in the pathological process of KBD by activating the Notch/Hes1 signalling pathway, leading to excessive chondrocyte apoptosis. Activation of Notch/Hes1 promotes oxidative damage, while supplementation with Se can reverse this oxidative damage ( 73 ). These findings suggest that targeting the Notch/Hes1 signalling pathway may be a novel therapeutic approach for the management of KBD.…”
Section: Selenium and Kashin-beck Diseasementioning
confidence: 99%
“…Some primary selenoprotein genes in mammals have central roles in Redox signaling (GPX1, GPX3, GPX4, TRXRD1, TRXRD2), Protein folding and degradation (SEP15, SELS), and metabolism (SEP1, SPS1, SPGS) [26,27]. Selenium deficiency is associated with Keshan disease [28,[28][29][30][31], muscle weakness [32], Kashin Beck [33][34][35][36][37], cardiomyopathy [38][39][40][41], and redox dysregulation [42]. In contrast, exposure to excessive amounts of selenium can lead to disorders such as selenosis, loss of hair and nails, redox dysregulation, mitochondrial dysfunction, and cell growth inhibition [43][44][45][46][47][48].…”
Section: Prevalence and Toxicity Of Metalloids 121 Seleniummentioning
confidence: 99%